GMP for Biopharma: Risk-Based Approach to Compliance
GMP for Biopharma: Risk-Based Approach to Compliance Understanding Risk-Based GMP Compliance in Biopharmaceutical Manufacturing Introduction: The Shift Toward Risk-Based Compliance The biopharmaceutical industry faces unique challenges due to the complexity of products, processes, and stringent regulatory requirements. Traditional compliance approaches often relied on universal standards for all manufacturing processes, which could lead to inefficiencies. Today,…
Read More “GMP for Biopharma: Risk-Based Approach to Compliance” »